Skip to main content
Caplight Logo









Braive AS

Braive AS

Private
OsloHealthcare & Life Scienceshttps://braive.com/

Last Round

VC Round

Feb 25, 2026

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Braive AS is a health technology company that provides a digital mental health platform offering evidence-based treatment programs, including Internet-based Cognitive Behavioural Therapy (iCBT), to healthcare providers and insurance companies.

Sector

Healthcare & Life Sciences

Verticals

Mental Health, Medical AI, Telemedicine, Patient Engagement, Medical Devices

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

digital therapeuticsDTxinternet-delivered cognitive behavioral therapyiCBTmental health platformAI scribeclinical documentationmedical AIclinical decision supporttelemedicineB2B SaaSpatient engagementmental health screeningAI health assistantdigital mental health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Braive AS Comparables

Compare Braive AS with similar companies based on industry and business-model similarity.

Braive AS comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Assistert Selvhjelp AS
85%
Limbic
81%
MEDICE Arzneimittel Pütter
77%

Braive AS Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundFeb 25, 2026

Key People

Founding team and executive leadership

Hermine Bonde Jahren

Co-Founder, CEO

Founding Team

Petra Tunkrans

CFO

Executive Team

Michell Hansson

COO

Executive Team

Noel Duarte

Chief Product Officer

Executive Team

Braive AS Investors

Notable investors and investment history

Braive AS investors
InvestorRounds
ScietyVC Round
Altitude CapitalVC Round
The Inner FoundationVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 25, 2026

    $3.1M raised from Altitude Capital and Sciety.

  • Feb 19, 2026

    Grew 25% QoQ, from 20 to 25 employees.

Braive AS Filings

Explore SEC and related filing metadata, where available.

Braive AS filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Braive AS's valuation, stock price, and market status.

Is Braive AS a public or private company?

Braive AS is a private company.

What is the current stock price of Braive AS?

Braive AS is a private company with no public stock price. No recent secondary market data is available.

How much is Braive AS worth (valuation)?

Valuation information for Braive AS is not publicly available.

Can I buy Braive AS stock?

Braive AS shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Braive AS's last funding round?

Braive AS's most recent funding round was VC Round on February 25, 2026.

Who are the main investors in Braive AS?

Key investors in Braive AS include Sciety, Altitude Capital, The Inner Foundation.

Will Braive AS IPO soon?

No public IPO plans have been announced for Braive AS.

How can I track Braive AS secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Braive AS's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersOslo
Employee Range25
Year Founded2015
Last FundingFeb 25, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?